Related Experiment Video
Updated: Jun 3, 2026

Exploring the Effects of Spaceflight on Mouse Physiology using the Open Access NASA GeneLab Platform
Published on: January 13, 2019
Attenuated expression and function of the RECK tumor suppressor under hypoxic conditions is mediated by the MAPK
Hye Won Jeon1, Kyung-Ju Lee, Sun Hee Lee
1School of Life Sciences and Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu, Korea.
Abstract:
Downregulation of the tumor suppressor, reversion-inducing cysteine-rich protein with Kazal motifs (RECK) has been reported under hypoxic conditions (Lee et al., 2010); however, the signaling pathways involved in this downregulation have not yet been identified. Hypoxia causes the silencing of RECK mRNA expression, but treatment with inhibitors of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated kinase (MAPK) (PD98059, SP600125, and SB203580 respectively) or their dominant negative mutants recovered RECK suppression induced by hypoxia as analyzed with semiquantitative RT-PCR analysis and a RECK promoter luciferase assay. Hypoxia increased phosphorylation of ERK1/2, JNK and p38 MAPKs. The activities of matrix metalloproteinase (MMP)-9 and MMP-2 were increased under hypoxic conditions but treatment with PD98059, SP600125 and SB203580 inhibited their activation in cancer cells, as seen by zymography. Moreover, treatment with the inhibitors blocked cancer cell migration induced by hypoxia in H-Ras transformed MCF10A mammary cells. RECK suppression under hypoxic conditions was inversely related to HIF-1α expression; however, treatment with PD98059, SP600125 and SB203580 did not influence binding of HIF-1α to the reverse hypoxia responsive element site of the RECK promoter in a DNA precipitation assay. These results suggest that the ERK, JNK and p38 MAPK signaling pathways are indirectly involved in RECK suppression but are not involved in the binding activity of HIF-1α to the reverse hypoxia responsive element site on the RECK promoter under hypoxic conditions.
Insights
Hypoxia downregulates the tumor suppressor RECK (reversion-inducing cysteine-rich protein with Kazal motifs) via ERK, JNK, and p38 MAPK pathways, indirectly affecting cancer cell migration and MMP activity.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- The tumor suppressor RECK (reversion-inducing cysteine-rich protein with Kazal motifs) is downregulated under hypoxic conditions.
- The specific signaling pathways mediating RECK downregulation by hypoxia remain unidentified.
Purpose of the Study:
- To elucidate the signaling pathways involved in hypoxia-induced RECK downregulation.
- To investigate the role of MAPK pathways in RECK suppression and its downstream effects on cancer cell behavior.
Main Methods:
- Semiquantitative RT-PCR and RECK promoter luciferase assays were used to analyze RECK mRNA expression and promoter activity.
- Western blotting assessed MAPK phosphorylation, while zymography evaluated matrix metalloproteinase (MMP) activity.
- Cell migration assays and DNA precipitation assays were employed to study cancer cell migration and HIF-1α binding.
Main Results:
- Hypoxia suppressed RECK mRNA expression, which was reversed by inhibiting ERK, JNK, and p38 MAPK pathways.
- Hypoxia increased phosphorylation of ERK, JNK, and p38 MAPKs, and elevated MMP-2 and MMP-9 activities.
- Inhibiting these MAPK pathways blocked hypoxia-induced cancer cell migration and did not affect HIF-1α binding to the RECK promoter.
Conclusions:
- ERK, JNK, and p38 MAPK signaling pathways are indirectly involved in hypoxia-induced RECK suppression.
- These pathways mediate RECK downregulation independently of HIF-1α's direct binding to the RECK promoter, influencing cancer cell migration and MMP activity.
Related Concept Videos
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation
